Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 706 Extension Study
NCT00360867Phase 2Terminated
- Sponsor
- Amgen
- Start
- Dec 2005
- Primary completion
- Jul 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of motesanib in solid tumor, sponsored by Amgen. Started Dec 2005; status: terminated.
02
Drugs
motesanib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00360867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360867.